₹ 2.49
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Transgene Biotek Ltd. is a biotechnology enterprise focused on the development and commercialization of diagnostic kits. The company is also active in the manufacturing and oral formulation of diverse proteins through its distinctive TrabiORAL technology. Its array of products includes TrabiDHA, Tacrolimus, and Orlistat. K. Koteswara Rao established the firm in 1991, and its primary operations are based in Hyderabad, India.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Data is available to registered users only